Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.26.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
REVENUES $ 958 $ 721
COST OF REVENUES 723 470
GROSS PROFIT 235 251
OPERATING EXPENSES:    
Research and development expenses 689 681
Sales and marketing expenses 675 666
General and administrative expenses 734 716
TOTAL OPERATING EXPENSES 2,098 2,063
OPERATING LOSS (1,863) (1,812)
Interest expense (14) (34)
Other Financial expense, net (579) (14)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (2,456) $ (1,860)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.16) $ (2.18)
Net loss per share attributable to common shareholders diluted (in Dollars per share) $ (0.16) $ (2.18)
Weighted average number of common stocks used in computing net loss per share – basic (in Shares) 15,579,527 852,011
Weighted average number of common stocks used in computing net loss per share diluted (in Shares) 15,579,527 852,011